Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies

References

• Shive MS, Anderson JM. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28:5–24.
   PubMed Web of Science ®Google Scholar
• Jain RA. (2000). The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials, 21:2475–2490.
   PubMed Web of Science ®Google Scholar
• Bala I, Hariharan S, Kumar MN. (2004). PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst, 21:387–422.
   PubMed Web of Science ®Google Scholar
• Nahata T, Saini TR. (2008). D-optimal designing and optimization of long acting microsphere-based injectable formulation of aripiprazole. Drug Dev Ind Pharm, 34:668–675.
   PubMed Web of Science ®Google Scholar
• Yoncheva K, Lambov N, Miloshev S. (2009). Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol. Drug Dev Ind Pharm, 35:449–454.
   PubMed Web of Science ®Google Scholar
• Kollipara S, Bende G, Movva S, Saha R. (2010). Application of rotatable central composite design in the preparation and optimization of poly(lactic-co-glycolic acid) nanoparticles for controlled delivery of paclitaxel. Drug Dev Ind Pharm, 36:1377–1387.
   PubMed Web of Science ®Google Scholar
• Shi K, Cui F, Yamamoto H, Kawashima Y. (2009). Optimized formulation of high-payload PLGA nanoparticles containing insulin-lauryl sulfate complex. Drug Dev Ind Pharm, 35:177–184.
   PubMed Web of Science ®Google Scholar
• Niu X, Zou W, Liu C, Zhang N, Fu C. (2009). Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles. Drug Dev Ind Pharm, 35:1375–1383.
   PubMed Web of Science ®Google Scholar
• Quintanar-Guerrero D, Allémann E, Fessi H, Doelker E. (1998). Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm, 24:1113–1128.
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Shen Q, He H, Zhang Y. (2011). Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Dev Ind Pharm, 37:1339–1346.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jiang G, Qiu T, Ding F. (2012). Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery. Drug Dev Ind Pharm, 38:1039–1046.
   PubMed Web of Science ®Google Scholar
• Allen TM. (2002). Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer, 2:750–763.
   PubMed Web of Science ®Google Scholar
• Visser CC, Stevanovic S, Heleen Voorwinden L, Gaillard PJ, Crommelin DJ, Danhof M et al. (2004). Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target, 12:145–150.
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hekmatara T, Herbert E, Kreuter J. (2009). Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur J Pharm Biopharm, 71:251–256.
   PubMed Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q et al. (2009). Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. J Control Release, 134:55–61.
   PubMed Web of Science ®Google Scholar
• Huang R, Ke W, Han L, Liu Y, Shao K, Jiang C et al. (2010). Lactoferrin-modified nanoparticles could mediate efficient gene delivery to the brain in vivo. Brain Res Bull, 81:600–604.
   PubMed Web of Science ®Google Scholar
• Bamigbade TA, Langford RM. (1998). Tramadol hydrochloride: an overview of current use. Hosp Med, 59:373–376.
   PubMed Web of Science ®Google Scholar
• Cochran WG, Cox GM. (1957). Experimental Designs. 2nd edition. New York: Wiley.
   Google Scholar
• Seth AK, Misra A. (2002). Mathematical modelling of preparation of acyclovir liposomes: reverse phase evaporation method. J Pharm Pharm Sci, 5:285–291.
   PubMed Web of Science ®Google Scholar
• El Assassy AE, Amin MM, Abdelbary AA. (2012). Immediate release three-layered chewing gum tablets of fenoprofen calcium: preparation, optimization and bioavailability studies in healthy human volunteers. Drug Dev Ind Pharm, 38:603–615.
   PubMed Web of Science ®Google Scholar
• Ss K, Jk B, Cc G, Ym C, Nn I, Vk M. (2013). Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: an industrially feasible approach. Drug Dev Ind Pharm, 39:138–145.
   PubMed Web of Science ®Google Scholar
• Derakhshandeh K, Erfan M, Dadashzadeh S. (2007). Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm, 66:34–41.
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. (1989). Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm, 55:R1–R4.
   Web of Science ®Google Scholar
• Huang YB, Tsai YH, Lee SH, Chang JS, Wu PC. (2005). Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int J Pharm, 289:87–95.
   PubMed Web of Science ®Google Scholar
• Adinarayana K, Ellaiah P. (2002). Response surface optimization of the critical medium components for the production of alkaline protease by a newly isolated Bacillus sp. J Pharm Pharm Sci, 5:272–278.
   PubMed Web of Science ®Google Scholar
• Akhnazarova S, Kafarov V. (1982). Experiment Optimization in Chemistry and Chemical Engineering. Moscow: Mir.
   Google Scholar
• Derringer G, Suich R. (1980). Simultaneous-optimization of several response variables. J Qual Technol, 12:214–219.
   Web of Science ®Google Scholar
• Giry K, Viana M, Genty M, Wüthrich P, Chulia D. (2010). Surface responses and desirability functions to determine optimal granulation domains. Drug Dev Ind Pharm, 36:1016–1026.
   PubMed Web of Science ®Google Scholar
• Gupta S, Agarwal A, Gupta NK, Saraogi G, Agrawal H, Agrawal GP. (2012). Galactose decorated PLGA nanoparticles for hepatic delivery of acyclovir. Drug Dev Ind Pharm, 0(0):1–8.
   Google Scholar
• Joshi D, Lan-Chun-Fung Y, Pritchard J. (1979). Determination of poly (vinyl alcohol) via its complex with boric acid and iodine. Anal Chim Acta, 104:153–160.
   Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. (2005). Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm, 2:373–383.
   PubMed Web of Science ®Google Scholar
• Olivier JC, Huertas R, Lee HJ, Calon F, Pardridge WM. (2002). Synthesis of pegylated immunonanoparticles. Pharm Res, 19:1137–1143.
   PubMed Web of Science ®Google Scholar
• Q1A(R2). (2003). Stability testing of new drug substances and products.
   Google Scholar
• Zimmermann M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain, 16:109–110.
   PubMed Web of Science ®Google Scholar
• Woolfe G, MacDonald A. (1944). The evaluation of the analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther, 80:300.
   Google Scholar
• Armstrong NA. (2006). Pharmaceutical Experimental Design and Interpretation. 2nd edition. Boca Raton, FL: CRC/Taylor & Francis.
   Google Scholar
• Moghimi SM, Hedeman H, Muir IS, Illum L, Davis SS. (1993). An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta, 1157:233–240.
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. (2002). Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release, 82:105–114.
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Hou S, Xu F, Zhao R, He J et al. (2008). Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency. Eur J Pharm Biopharm, 69:445–453.
   PubMed Web of Science ®Google Scholar
• Song X, Zhao Y, Wu W, Bi Y, Cai Z, Chen Q et al. (2008). PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int J Pharm, 350:320–329.
   PubMed Web of Science ®Google Scholar
• Galindo-Rodriguez S, Allémann E, Fessi H, Doelker E. (2004). Physicochemical parameters associated with nanoparticle formation in the salting-out, emulsification-diffusion, and nanoprecipitation methods. Pharm Res, 21:1428–1439.
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. (2005). Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol. J Microencapsul, 22:773–785.
   PubMed Web of Science ®Google Scholar
• Chacón M, Molpeceres J, Berges L, Guzmán M, Aberturas MR. (1999). Stability and freeze-drying of cyclosporine loaded poly (D,L-lactide-glycolide) carriers. Eur J Pharm Sci, 8:99–107.
   PubMed Web of Science ®Google Scholar
• Franks F. (1998). Freeze-drying of bioproducts: putting principles into practice. Eur J Pharm Biopharm, 45:221–229.
   PubMed Web of Science ®Google Scholar
• Sameti M, Bohr G, Ravi Kumar MN, Kneuer C, Bakowsky U, Nacken M et al. (2003). Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int J Pharm, 266:51–60.
   PubMed Web of Science ®Google Scholar
• Konan YN, Gurny R, Allémann E. (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm, 233:239–252.
   PubMed Web of Science ®Google Scholar
• De Jaeghere F, Allémann E, Leroux JC, Stevels W, Feijen J, Doelker E et al. (1999). Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res, 16:859–866.
   PubMed Web of Science ®Google Scholar
• Chorny M, Fishbein I, Danenberg HD, Golomb G. (2002). Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release, 83:389–400.
   PubMed Web of Science ®Google Scholar
• Betancourt T, Brown B, Brannon-Peppas L. (2007). Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine (Lond), 2:219–232.
   PubMed Web of Science ®Google Scholar
• Talukder MJ, Takeuchi T, Harada E. (2003). Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. J Vet Med Sci, 65:957–964.
   PubMed Web of Science ®Google Scholar
• Huang RQ, Ke WL, Qu YH, Zhu JH, Pei YY, Jiang C. (2007). Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain. J Biomed Sci, 14:121–128.
   PubMed Web of Science ®Google Scholar
• Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaïssa M, Spik G et al. (1999). Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem, 274:7011–7017.
   PubMed Web of Science ®Google Scholar